Class III
Drug Recall: Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08
Zydus Pharmaceuticals (USA) Inc · May 16, 2024
Reason for Recall
Failed Impurities/Degradation Specifications.
Product Description
Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8
Distribution
Nationwide within the United States
States Affected
NATIONWIDE
Quantity Affected
13,440 units
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0543-2024
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.